U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    Klrk1 killer cell lectin-like receptor subfamily K, member 1 [ Mus musculus (house mouse) ]

    Gene ID: 27007, updated on 2-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    NKG2D knockdown improves hypoxic-ischemic brain damage by inhibiting neuroinflammation in neonatal mice.

    NKG2D knockdown improves hypoxic-ischemic brain damage by inhibiting neuroinflammation in neonatal mice.
    Liu L, Yang Y, Wu T, Du J, Long F., Free PMC Article

    03/1/2024
    NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis.

    NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis.
    Marinović S, Lenartić M, Mladenić K, Šestan M, Kavazović I, Benić A, Krapić M, Rindlisbacher L, Cokarić Brdovčak M, Sparano C, Litscher G, Turk Wensveen T, Mikolašević I, Fučkar Čupić D, Bilić-Zulle L, Steinle A, Waisman A, Hayday A, Tugues S, Becher B, Polić B, Wensveen FM., Free PMC Article

    02/15/2024
    IL-17a-producing gammadeltaT cells and NKG2D signaling mediate bacterial endotoxin-induced neonatal lung injury: implications for bronchopulmonary dysplasia.

    IL-17a-producing γδT cells and NKG2D signaling mediate bacterial endotoxin-induced neonatal lung injury: implications for bronchopulmonary dysplasia.
    Cui TX, Brady AE, Zhang YJ, Anderson C, Popova AP., Free PMC Article

    09/29/2023
    CD8[+] T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis.

    CD8(+) T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis.
    Lerner EC, Woroniecka KI, D'Anniballe VM, Wilkinson DS, Mohan AA, Lorrey SJ, Waibl-Polania J, Wachsmuth LP, Miggelbrink AM, Jackson JD, Cui X, Raj JA, Tomaszewski WH, Cook SL, Sampson JH, Patel AP, Khasraw M, Gunn MD, Fecci PE., Free PMC Article

    09/27/2023
    TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses.

    TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses.
    Harris R, Mammadli M, Hiner S, Suo L, Yang Q, Sen JM, Karimi M., Free PMC Article

    05/30/2023
    Regulatory T cells suppress the formation of potent KLRK1 and IL-7R expressing effector CD8 T cells by limiting IL-2.

    Regulatory T cells suppress the formation of potent KLRK1 and IL-7R expressing effector CD8 T cells by limiting IL-2.
    Tsyklauri O, Chadimova T, Niederlova V, Kovarova J, Michalik J, Malatova I, Janusova S, Ivashchenko O, Rossez H, Drobek A, Vecerova H, Galati V, Kovar M, Stepanek O., Free PMC Article

    03/4/2023
    Tissue origin of cytotoxic natural killer cells dictates their differential roles in mouse digit tip regeneration and progenitor cell survival.

    Tissue origin of cytotoxic natural killer cells dictates their differential roles in mouse digit tip regeneration and progenitor cell survival.
    Dastagir N, Beal Z, Godwin J., Free PMC Article

    05/7/2022
    Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy.

    Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy.
    Banerjee A, Li D, Guo Y, Mahgoub B, Paragas L, Slobin J, Mei Z, Manafi A, Hata A, Li K, Shi L, Westwick J, Slingluff C, Lazear E, Krupnick AS., Free PMC Article

    01/8/2022
    The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation.

    The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation.
    Lin CM, Gill RG, Mehrad B., Free PMC Article

    11/13/2021
    NKG2D Enhances Double-Negative T Cell Regulation of B Cells.

    NKG2D Enhances Double-Negative T Cell Regulation of B Cells.
    Hu SH, Zhang LH, Gao J, Guo JH, Xun XD, Xiang X, Cheng Q, Li Z, Zhu JY., Free PMC Article

    10/2/2021
    NKG2D defines tumor-reacting effector CD8(+) T cells within tumor microenvironment.

    NKG2D defines tumor-reacting effector CD8(+) T cells within tumor microenvironment.
    Mojic M, Shitaoka K, Ohshima C, Ucche S, Lyu F, Hamana H, Tahara H, Kishi H, Hayakawa Y., Free PMC Article

    09/18/2021
    Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury.

    Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury.
    Calabrese DR, Aminian E, Mallavia B, Liu F, Cleary SJ, Aguilar OA, Wang P, Singer JP, Hays SR, Golden JA, Kukreja J, Dugger D, Nakamura M, Lanier LL, Looney MR, Greenland JR., Free PMC Article

    09/11/2021
    Deficiency of miR-15a/16 upregulates NKG2D in CD8(+) T cells to exacerbate dextran sulfate sodium-induced colitis.

    Deficiency of miR-15a/16 upregulates NKG2D in CD8(+) T cells to exacerbate dextran sulfate sodium-induced colitis.
    Jia X, Wei Y, Miao X, Zhu T, Hu X, Lin Z, Xiao W, Zhang Y, Wang Z, Gong W.

    07/17/2021
    NK cell receptor NKG2D enforces proinflammatory features and pathogenicity of Th1 and Th17 cells.

    NK cell receptor NKG2D enforces proinflammatory features and pathogenicity of Th1 and Th17 cells.
    Babic M, Dimitropoulos C, Hammer Q, Stehle C, Heinrich F, Sarsenbayeva A, Eisele A, Durek P, Mashreghi MF, Lisnic B, Van Snick J, Löhning M, Fillatreau S, Withers DR, Gagliani N, Huber S, Flavell RA, Polic B, Romagnani C., Free PMC Article

    03/6/2021
    Loss of NKG2D in murine NK cells leads to increased perforin production upon long-term stimulation with IL-2.

    Loss of NKG2D in murine NK cells leads to increased perforin production upon long-term stimulation with IL-2.
    Prinz D, Klein K, List J, Knab VM, Menzl I, Leidenfrost N, Heller G, Polić B, Putz EM, Witalisz-Siepracka A, Sexl V, Gotthardt D., Free PMC Article

    12/12/2020
    Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway.

    Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway.
    Alvarez M, Simonetta F, Baker J, Pierini A, Wenokur AS, Morrison AR, Murphy WJ, Negrin RS., Free PMC Article

    10/24/2020
    Concomitant deletion of SLAM-family receptors, NKG2D and DNAM-1 reveals gene redundancy of NK cell activating receptors in NK cell development and education.

    Concomitant deletion of SLAM-family receptors, NKG2D and DNAM-1 reveals gene redundancy of NK cell activating receptors in NK cell development and education.
    Chen S, Dong Z.

    08/15/2020
    The NK cell activation receptor, NKG2D, plays a key role in NK cell cytotoxicity of embryonic stem cell-derived hepatocyte-like cells (HLC), but not induced pluripotent stem cell-derived HLC.

    Differential role of natural killer group 2D in recognition and cytotoxicity of hepatocyte-like cells derived from embryonic stem cells and induced pluripotent stem cells.
    Cisneros T, Dillard DW, Qu X, Arredondo-Guerrero J, Castro M, Schaffert S, Martin R, Esquivel CO, Krams SM, Martinez OM., Free PMC Article

    07/18/2020
    The interaction between immune cells and cardiomyocytes via NKG2D/NKG2DL induces cardiomyocyte death, exacerbating cardiac remodelling after myocardial infarction.

    Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction.
    Matsumoto K, Obana M, Kobayashi A, Kihara M, Shioi G, Miyagawa S, Maeda M, Sakata Y, Nakayama H, Sawa Y, Fujio Y.

    05/9/2020
    Signaling through NKG2D during the effector phase (certification) favors the development of functional memory CD8 T cells, a previously undescribed role for NKG2D.

    NKG2D signaling certifies effector CD8 T cells for memory formation.
    Perez C, Prajapati K, Burke B, Plaza-Rojas L, Zeleznik-Le NJ, Guevara-Patino JA., Free PMC Article

    04/4/2020
    Our data support the notion that endogenous CD8 T cells contribute to passive EAE pathobiology in a NKG2D-dependent manner. Collectively, our results point to the deleterious role of NKG2D and its MULT1 in the pathobiology of a MS mouse model.

    NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis.
    Legroux L, Moratalla AC, Laurent C, Deblois G, Verstraeten SL, Arbour N., Free PMC Article

    01/11/2020
    Studied role of killer cell lectin-like receptor subfamily K member 1 (NKG2D) in immune response of Respiratory Syncytial Virus Infection in wild-type and knockout mice.

    NKG2D Regulation of Lung Pathology and Dendritic Cell Function Following Respiratory Syncytial Virus Infection.
    Liu H, Osterburg AR, Flury J, Huang S, McCormack FX, Cormier SA, Borchers MT., Free PMC Article

    09/21/2019
    Iqgap1(-/-) NK cells failed to fully induce S6 phosphorylation and showed significantly reduced protein translation following NKG2D-mediated activation, revealing a previously undefined regulatory function of IQGAP1 via the mechanistic target of rapamycin complex 1.

    IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells.
    Abel AM, Tiwari AA, Gerbec ZJ, Siebert JR, Yang C, Schloemer NJ, Dixon KJ, Thakar MS, Malarkannan S., Free PMC Article

    08/17/2019
    NKG2D is an essential receptor required for the activation of iNKT cells in Con A-induced hepatitis

    Critical Contribution of NK Group 2 Member D Expressed on Invariant Natural Killer T Cells in Concanavalin A-Induced Liver Hepatitis in Mice.
    Al Dulaimi D, Klibi J, Olivo Pimentel V, Parietti V, Allez M, Toubert A, Benlagha K., Free PMC Article

    07/13/2019
    Data show that indoleamine 2,3 dioxygenase-1 (IDO1)/ miR-18a/ killer cell lectin-like receptor subfamily K (NKG2D/NKG2DL) regulatory axis in the regulation of NK cell function.

    IDO1 impairs NK cell cytotoxicity by decreasing NKG2D/NKG2DLs via promoting miR-18a.
    Zhang J, Han X, Hu X, Jin F, Gao Z, Yin L, Qin J, Yin F, Li C, Wang Y.

    05/4/2019
    firstprevious page of 6 nextlast